Cancer risk of incremental exposure to polycyclic aromatic hydrocarbons in electrocautery smoke for mastectomy personnel

World Journal of Surgical Oncology

Dar-Ren Chen³  Yao-Jen Liu¹  Shien-Chih Lee¹  Li-Ru Yang¹  Shi-Nian Uang¹  Shi-Ping Liu²  Hsin-Shun Tseng³ 

[1] Institute of Occupational Safety and Health, Council of Labor Affairs, 99, Lane 407, Hengke Road, New Taipei 22143, Taiwan;Department of Public Health, Fu-Jen Catholic University, 510 Zhongzheng Road, New Taipei 24205, Taiwan;Comprehensive Breast Cancer Center, Changhua Christian Hospital, 135 Nanhsiao Street, Changhua 50006, Taiwan

关键词: Toxicity equivalency factor;    Surgical staff;    Polycyclic aromatic hydrocarbons;    Electrocautery smoke;    Cancer risk;   

Others  :  820426
DOI  :  10.1186/1477-7819-12-31

 received in 2013-07-09, accepted in 2014-01-28,  发布年份 2014

【 摘 要 】

Background

Electrocautery applications in surgical operations produce evasive odorous smoke in the cleanest operation rooms. Because of the incomplete combustion of electrical current in the tissues and blood vessels during electrocautery applications, electrocautery smoke (ES) containing significant unknown chemicals and biological forms is released. The potential hazards and cancer risk should be further investigated from the perspective of the occupational health of surgical staff.

Methods

The particle number concentration and the concentration of polycyclic aromatic hydrocarbons (PAHs) in ES were thoroughly investigated in 10 mastectomies to estimate the cancer risk for surgical staff. The particle number concentration and gaseous/particle PAHs at the surgeons’ and anesthetic technologists’ (AT) breathing heights were measured with a particle counter and filter/adsorbent samplers. PAHs were soxhlet-extracted, cleaned, and analyzed by gas chromatography/mass spectrometry.

Results

Abundant submicron particles and high PAH concentrations were found in ES during regular surgical mastectomies. Most particles in ES were in the size range of 0.3 to 0.5 μm, which may potentially penetrate through the medical masks into human respiration. The average particle/gaseous phase PAH concentrations at the surgeon’s breathing height were 131 and 1,415 ng/m³, respectively, which is 20 to 30 times higher than those in regular outdoor environments. By using a toxicity equivalency factor, the cancer risk for the surgeons and anesthetic technologists was calculated to be 117 × 10^-6 and 270 × 10^-6, respectively; the higher cancer risk for anesthetic technologists arises due to the longer working hours in operation rooms.

Conclusions

The carcinogenic effects of PAHs in ES on the occupational health of surgical staff should not be neglected. The use of an effective ES evacuator or smoke removal apparatus is strongly suggested to diminish the ES hazards to surgical staff.

【 授权许可】

   
2014 Tseng et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】

• [1]Alp E, Bijl D, Bleichrodt RP, Hansson B, Voss A: Surgical smoke and infection control. J Hosp Infect 2006, 62:1-5.
• [2]Beebe DS, Swica H, Carlson N, Palahniuk RJ, Goodale RL: High levels of carbon monoxide are produced by electro-cautery of tissue during laparoscopic cholecystectomy. Anesth Analg 1993, 77:338-341.
• [3]Brook RD, Franklin B, Cascio W, Hong Y, Howard G, Lipsett M, Luepker R, Mittleman M, Samet J, Smith SC Jr, Tager I: Air pollution and cardiovascular disease: a statement for healthcare professionals from the Expert Panel on Population and Prevention Science of the American Heart Association. Circulation 2004, 109:2655-2671.
• [4]Hensman C, Baty D, Willis RG, Cuschieri A: Chemical composition of smoke produced by high-frequency electrosurgery in a closed gaseous environment. An in vitro study. Surg Endosc 1998, 12:1017-1019.
• [5]Barrett WL, Garber SM: Surgical smoke: a review of the literature. Is this just a lot of hot air? Surg Endosc 2003, 17:979-987.
• [6]Garden JM, O’Banion MK, Shelnitz LS, Pinski KS, Bakus AD, Reichmann ME, Sundberg JP: Papillomavirus in the vapor of carbon dioxide laser-treated verrucae. JAMA 1988, 259:1199-1202.
• [7]Ferenczy A, Bergeron C, Richart RM: Human papillomavirus DNA in CO2 laser-generated plume of smoke and its consequences to the surgeon. Obstet Gynecol 1990, 75:114-118.
• [8]Fletcher JN, Mew D, DesCoteaux JG: Dissemination of melanoma cells within electrocautery plume. Am J Surg 1999, 178:57-59.
• [9]Gatti JE, Bryant CJ, Noone RB, Murphy JB: The mutagenicity of electrocautery smoke. Plast Reconstr Surg 1992, 89:781-784. Discussion 785–786
• [10]Bruske-Hohlfeld I, Preissler G, Jauch KW, Pitz M, Nowak D, Peters A, Wichmann HE: Surgical smoke and ultrafine particles. J Occup Med Toxicol 2008, 3:31. BioMed Central Full Text
• [11]Rioux M, Garland A, Webster D, Reardon E: HPV positive tonsillar cancer in two laser surgeons: case reports. J Otolaryngol Head Neck Surg 2013, 42:54. BioMed Central Full Text
• [12]Biggins J, Renfree S: The hazards of surgical smoke. Not to be sniffed at! Br J Perioper Nurs 2002, 12:136-138. Discussion 141–133
• [13]Menzie CA, Potocki BB, Santodonato J: Exposure to carcinogenic PAHs in the environment. Environ Sci Technol 1992, 26:1278-1284.
• [14]Tang D, Cho S, Rundle A, Chen S, Phillips D, Zhou J, Hsu Y, Schnabel F, Estabrook A, Perera FP: Polymorphisms in the DNA repair enzyme XPD are associated with increased levels of PAH-DNA adducts in a case–control study of breast cancer. Breast Cancer Res Treat 2002, 75:159-166.
• [15]Office of the Federal Registration (OFR) Appendix A: Priority pollutants. Fed Regist 1982, 47:52309.
• [16]Yan J, Wang L, Fu PP, Yu H: Photomutagenicity of 16 polycyclic aromatic hydrocarbons from the US EPA priority pollutant list. Mutat Res 2004, 557:99-108.
• [17]Pliskova M, Vondracek J, Vojtesek B, Kozubik A, Machala M: Deregulation of cell proliferation by polycyclic aromatic hydrocarbons in human breast carcinoma MCF-7 cells reflects both genotoxic and nongenotoxic events. Toxicol Sci 2005, 83:246-256.
• [18]Nisbet IC, LaGoy PK: Toxic equivalency factors (TEFs) for polycyclic aromatic hydrocarbons (PAHs). Regul Toxicol Pharmacol 1992, 16:290-300.
• [19]Yeh HC, Cuddihy RG, Phalen RF, Chang IY: Comparisons of calculated respiratory tract deposition of particles based on the proposed NCRP model and the New ICRP66 model. Aerosol Sci Technol 1996, 25:134-140.
• [20]Law RJ, Kelly C, Baker K, Jones J, McIntosh AD, Moffat CF: Toxic equivalency factors for PAH and their applicability in shellfish pollution monitoring studies. J Environ Monit 2002, 4:383-388.